Skip to main content

KSHV After an Organ Transplant: Should We Screen?

  • Chapter
Kaposi Sarcoma Herpesvirus: New Perspectives

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 312))

Abstract

The incidence of Kaposi sarcoma (KS) related to Kaposi sarcoma-associated herpesvirus (KSHV/HHV-8) after organ transplantation is 500–1,000 times greater than in the general population, and its occurrence is associated with immunosuppressive therapy. The reported incidence of posttransplant KS ranges from 0.5% to 5%, depending on the patient’s country of origin and the type of organ received, mainly after renal transplantation. Posttransplant KS is caused by two possible mechanisms: KSHV reactivation in patients who were infected before the graft and KSHV contamination from the infected organ’s donor to the recipient. KSHV reactivation appears to play a greater role in the risk of KS than incident infections. However, some studies, with findings based not only on serological data but also on molecular tracing of the viral infection, have shown that organ-related transmission of KSHV could be more common than previously thought and associated in some cases with severe KSHV-related disease. Precise estimates of KSHV seroprevalence in the organ donor and recipient populations in different countries are lacking. However, studies have reported seroprevalences among donors and recipients that are similar to those among the general population of the country considered. Many studies have suggested the potential utility of screening of KSHV antibodies among organ donors and recipients. However, to date the results of these studies have argued in favor of KSHV screening, even in low-KSHV infection prevalence countries, not to exclude the graft but to have the KSHV status information in order to have the opportunity to monitor, clinically and biologically, patients at risk for KSHV-related disease development. The detection of KSHV antibodies could be done in the days after the transplantation and the results transmitted to the physicians retrospectively. In conclusion, the question of screening donors and recipients for KSHV, even in low-KSHV infection prevalence countries, is still debated, and prospective studies are needed to evaluate the benefit of pre- and posttransplantation strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ablashi DV, Chatlynne LG, Whitman JE Jr, Cesarman E (2002) Spectrum of Kaposi’s sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev 15, 439–64

    Article  PubMed  Google Scholar 

  • Andreoni M, Goletti D, Pezzotti P, Pozzetto A, Monini P, Sarmati L, Farchi F, Tisone G, Piazza A, Pisani F, Angelico M, Leone P, Citterio F, Ensoli B, Rezza G (2001) Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi’s sarcoma in renal and liver transplant recipients. J Infect 43, 195–9

    Article  PubMed  CAS  Google Scholar 

  • Aseni P, Vertemati M, Minola E, Arcieri K, Bonacina E, Camozzi M, Osio C, Forti D (2001) Kaposi’s sarcoma in liver transplant recipients: morphological and clinical description. Liver Transpl 7, 816–23

    Article  PubMed  CAS  Google Scholar 

  • Barozzi P, Luppi M, Facchetti F, Mecucci C, Alu M, Sarid R, Rasini V, Ravazzini L, Rossi E, Festa S, Crescenzi B, Wolf DG, Schulz TF, Torelli G (2003) Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med 9, 554–61

    Article  PubMed  CAS  Google Scholar 

  • Behrend M, Kolditz M, Kliem V, Oldhafer KJ, Brunkhorst R, Frei U, Pichlmayr R (1997) Malignancies in patients under long-term immunosuppression after kidney transplantation. Transplant Proc 29, 834–5

    Article  PubMed  CAS  Google Scholar 

  • Belec L, Cancre N, Hallouin MC, Morvan J, Si Mohamed A, Gresenguet G (1998) High prevalence in Central Africa of blood donors who are potentially infectious for human herpesvirus 8. Transfusion 38, 771–5

    Article  PubMed  CAS  Google Scholar 

  • Besnard V, Euvrard S, Kanitakis J, Mion F, Boillot O, Frances C, Faure M, Claudy A (1996) Kaposi’s sarcoma after liver transplantation. Dermatology 193, 100–4

    Article  PubMed  CAS  Google Scholar 

  • Biggar RJ, Engels EA, Whitby D, Kedes DH, Goedert JJ (2003) Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men. J Infect Dis 187, 12–8

    Article  PubMed  Google Scholar 

  • Briz M, Alonso-Pulpon L, Crespo-Leiro MG, Exposito C, Almagro M, Busto MJ, Fernandez MN (1998) Detection of herpesvirus-like sequences in Kaposi’s sarcoma from heart transplant recipients. J Heart Lung Transplant 17, 288–93

    PubMed  CAS  Google Scholar 

  • Brunson ME, Balakrishnan K, Penn I (1990) HLA and Kaposi’s sarcoma in solid organ transplantation. Hum Immunol 29, 56–63

    Article  PubMed  CAS  Google Scholar 

  • Calabro ML, Sheldon J, Favero A, Simpson GR, Fiore JR, Gomes E, Angarano G, Chieco-Bianchi L, Schulz TF (1998) Seroprevalence of Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. J Hum Virol 1, 207–13

    PubMed  CAS  Google Scholar 

  • Cattani P, Capuano M, Graffeo R, Ricci R, Cerimele F, Cerimele D, Nanni G, Fadda G (2001) Kaposi’s sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients. J Clin Microbiol 39, 506–8

    Article  PubMed  CAS  Google Scholar 

  • Cockburn IT, Krupp P (1989) The risk of neoplasms in patients treated with cyclosporine A. J Autoimmun 2, 723–31

    Article  PubMed  CAS  Google Scholar 

  • Colina F, Lopez-Rios F, Lumbreras C, Martinez-Laso J, Garcia IG, Moreno-Gonzalez E (1996) Kaposi’s sarcoma developing in a liver graft. Transplantation 61, 1779–81

    Article  PubMed  CAS  Google Scholar 

  • Corbellino M, Bestetti G, Scalamogna C, Calattini S, Galazzi M, Meroni L, Manganaro D, Fasan M, Moroni M, Galli M, Parravicini C (2001) Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 98, 3473–5

    Article  PubMed  CAS  Google Scholar 

  • Demirag A, Hizel N, Karakayali H, Moray G, Akkoc H, Bilgin N, Haberal M (1998) Kaposi sarcoma-associated herpesvirus/human herpesvirus type 8 and Epstein-Barr virus in immunosuppressed renal transplant recipients. Transplant Proc 30, 3166–7

    Article  PubMed  CAS  Google Scholar 

  • Dupin N, Rubin De Cervens V, Gorin I, Calvez V, Pessis E, Grandadam M, Rabian C, Viard JP, Huraux JM, Escande JP (1999) The influence of highly active antiretroviral therapy on AIDS-associated Kaposi’s sarcoma. Br J Dermatol 140, 875–81

    Article  PubMed  CAS  Google Scholar 

  • Eberhard OK, Kliem V, Brunkhorst R (1999) Five cases of Kaposi’s sarcoma in kidney graft recipients: possible influence of the immunosuppressive therapy. Transplantation 67, 180–4

    Article  PubMed  CAS  Google Scholar 

  • Ecder ST, Sever MS, Yildiz A, Turkmen A, Kayacan SM, Kilicaslan I, Kocak T, Eldegez U (1998) Kaposi’s sarcoma after renal transplantation in Turkey. Clin Transplant 12, 472–5

    PubMed  CAS  Google Scholar 

  • Emond JP, Marcelin AG, Dorent R, Milliancourt C, Dupin N, Frances C, Agut H, Gandjbakhch I, Calvez V (2002) Kaposi’s sarcoma associatedwith previous human herpesvirus 8 infection in heart transplant recipients. J Clin Microbiol 40, 2217–9

    Article  PubMed  Google Scholar 

  • Engels EA, Whitby D, Goebel PB, Stossel A, Waters D, Pintus A, Contu L, Biggar RJ, Goedert JJ (2000) Identifying human herpesvirus 8 infection: performance characteristics of serologic assays. J Acquir Immune Defic Syndr 23, 346–54

    PubMed  CAS  Google Scholar 

  • Euvrard S, Kanitakis J, Claudy A (2003) Skin cancers after organ transplantation. N Engl J Med 348, 1681–91

    Article  PubMed  Google Scholar 

  • Farge D (1993) Kaposi’s sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France. Eur J Med 2, 339–43

    PubMed  CAS  Google Scholar 

  • Farge D, Lebbe C, Marjanovic Z, Tuppin P, Mouquet C, Peraldi MN, Lang P, Hiesse C, Antoine C, Legendre C, Bedrossian J, Gagnadoux MF, Loirat C, Pellet C, Sheldon J, Golmard JL, Agbalika F, Schulz TF (1999) Human herpes virus-8 and other risk factors for Kaposi’s sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d’ Ile de France (GCIF). Transplantation 67, 1236–42

    Article  PubMed  CAS  Google Scholar 

  • Fournet JC, Peuchmaur M, Eckart P, Gagnadoux MF, Stephan JL, Hubert P, Niaudet P, Brousse N (1992) Multicentric Kaposi’s sarcoma in a 5-year-old human immunodeficiency virus-negative renal allograft recipient. Hum Pathol 23, 956–60

    Article  PubMed  CAS  Google Scholar 

  • Frances C (1998) Kaposi’s sarcoma after renal transplantation. Nephrol Dial Transplant 13, 2768–73

    Article  PubMed  CAS  Google Scholar 

  • Frances C, Farge D, Desruennes M, Boisnic S (1991) Kaposi’s sarcoma in after heart transplantation. Ann Dermatol Venereol 118, 864–6

    PubMed  CAS  Google Scholar 

  • Frances C, Mouquet C, Calvez V (1999) Human herpesvirus 8 andrenal transplantation. N Engl J Med 340, 1045; author reply 1046

    Article  PubMed  CAS  Google Scholar 

  • Frances C, Mouquet C, Marcelin AG, Barete S, Agher R, Charron D, Benalia H, Dupin N, Piette JC, Bitker MO, Calvez V (2000) Outcome of kidney transplant recipients with previous human herpesvirus-8 infection. Transplantation 69, 1776–9

    Article  PubMed  CAS  Google Scholar 

  • Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, Saah A, Phair J, Detels R, Parry P, Chang Y, Moore PS (1996a) Seroconversion to antibodies against Kaposi’s sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi’s sarcoma. N Engl J Med 335, 233–41

    Article  PubMed  CAS  Google Scholar 

  • Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, Moore PS (1996b) KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma [see comments]. Nat Med 2, 925–8

    Article  PubMed  CAS  Google Scholar 

  • Goldstein DJ, Williams DL, Oz MC, Weinberg AD, Rose EA, Michler RE (1995) De novo solid malignancies after cardiac transplantation. Ann Thorac Surg 60, 1783–9

    Article  PubMed  CAS  Google Scholar 

  • Gomezdos Santos V, Burgos Revilla FJ, Pascual Santos J, Orofino Ascunce L, Fernandez-Juarez G, Crespo Martinez L, Clemente Ramos L, Carrera Puerta C, Marcen Letosa R, Escudero Barrilero A, Ortuno Mirete J (1997) [Neoplasm prevalence in renal transplantation]. Arch Esp Urol 50, 267–73; discussion 273–4

    CAS  Google Scholar 

  • Harwood AR, Osoba D, Hofstader SL, Goldstein MB, Cardella CJ, Holecek MJ, Kunynetz R, Giammarco RA (1979) Kaposi’s sarcomain recipients of renal transplants. Am J Med 67, 759–65

    Article  PubMed  CAS  Google Scholar 

  • Hiesse C, Larue JR, Kriaa F, Blanchet P, Bellamy J, Benoit G, Charpentier B (1995) Incidence and type of malignancies occurring after renal transplantation in conventionally and in cyclosporine-treated recipients: single-center analysis of a 20-year period in 1600 patients. Transplant Proc 27, 2450–1

    PubMed  CAS  Google Scholar 

  • Huang PM, Chang YL, Chen JS, Hsu HH, Ko WJ, Kuo SH, Lee YC (2003) Human herpesvirus-8 associated Kaposi’s sarcoma after lung transplantation: a case report. Transplant Proc 35, 447–9

    Article  PubMed  Google Scholar 

  • Hudnall SD, Rady PL, Tyring SK, Fish JC (1998) Serologic and molecular evidence of human herpesvirus 8 activation in renal transplant recipients. J Infect Dis 178, 1791–4

    Article  PubMed  CAS  Google Scholar 

  • Jenkins FJ, Hoffman LJ, Liegey-Dougall A (2002) Reactivation of and primary infection with human herpesvirus 8 among solid-organ transplant recipients. J Infect Dis 185, 1238–43

    Article  PubMed  Google Scholar 

  • Jones D, Ballestas ME, Kaye KM, Gulizia JM, Winters GL, Fletcher J, Scadden DT, Aster JC (1998) Primary-effusion lymphoma and Kaposi’s sarcoma in a cardiac-transplant recipient. N Engl J Med 339, 444–9

    Article  PubMed  CAS  Google Scholar 

  • Kaufman DB, Leventhal JR, Stuart J, Abecassis MM, Fryer JP, Stuart FP (1999) Mycophenolate mofetil and tacrolimus as primary maintenance immunosuppression in simultaneous pancreas-kidney transplantation: initial experience in 50 consecutive cases. Transplantation 67, 586–93

    Article  PubMed  CAS  Google Scholar 

  • Lanza RP, Cooper DK, Cassidy MJ, Barnard CN (1983) Malignant neoplasms occurring after cardiac transplantation. JAMA 249, 1746–8

    Article  PubMed  CAS  Google Scholar 

  • Lennette ET, Blackbourn DJ, Levy JA (1996) Antibodies to human herpesvirus type 8 in the general population and in Kaposi’s sarcoma patients. Lancet 348, 858–61

    Article  PubMed  CAS  Google Scholar 

  • Luppi M, Barozzi P, Schulz TF, Setti G, Staskus K, Trovato R, Narni F, Donelli A, Maiorana A, Marasca R, Sandrini S, Torelli G (2000) Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med 343, 1378–85

    Article  PubMed  CAS  Google Scholar 

  • Marcelin AG, Aaron L, Mateus C, Gyan E, Gorin I, Viard JP, Calvez V, Dupin N (2003) Rituximab therapy for HIV-associated Castleman disease. Blood 102, 2786–8

    Article  PubMed  CAS  Google Scholar 

  • Marcelin AG, Dupin N, Bossi P, Calvez V (1998) Seroprevalence of human herpesvirus-8 in healthy subjects and patients with AIDS-associated and classical Kaposi’s sarcoma in France. AIDS 12, 539–40

    PubMed  CAS  Google Scholar 

  • Marcelin AG, Milliancourt C, Dupin N, Wirden M, Huraux JM, Agut H, Calvez V (2001) Effects of cyclosporine and hydrocortisone on Kaposi’s sarcoma-associated herpesvirus genome replication and cell apoptosis induction. Transplantation 72, 1700–3

    Article  PubMed  CAS  Google Scholar 

  • Marcelin AG, Roque-Afonso AM, Hurtova M, Dupin N, Tulliez M, Sebagh M, Arkoub ZA, Guettier C, Samuel D, Calvez V, Dussaix E (2004) Fatal disseminated Kaposi’s sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients. Liver Transpl 10, 295–300

    Article  PubMed  Google Scholar 

  • Margolius L, Stein M, Spencer D, Bezwoda WR (1994) Kaposi’s sarcoma in renal transplant recipients. Experience at Johannesburg Hospital, 1966–1989. S Afr Med J 84, 16–7

    PubMed  CAS  Google Scholar 

  • Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, Robinson CA (1999) Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group [see comments]. N Engl J Med 340, 1063–70

    Article  PubMed  CAS  Google Scholar 

  • Mayama S, Cuevas LE, Sheldon J, Omar OH, Smith DH, Okong P, Silvel B, Hart CA, Schulz TF (1998) Prevalence and transmission of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 77, 817–20

    Article  PubMed  CAS  Google Scholar 

  • Milliancourt C, Barete S, Marcelin AG, Mouquet C, Dupin N, Frances C, Agut H, Bitker MO, Calvez V (2001) Human herpesvirus-8 seroconversions after renal transplantation. Transplantation 72, 1319–20

    Article  PubMed  CAS  Google Scholar 

  • Montagnino G, Bencini PL, Tarantino A, Caputo R, Ponticelli C (1994) Clinical features and course of Kaposi’s sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol 14, 121–6

    PubMed  CAS  Google Scholar 

  • Montagnino G, Lorca E, Tarantino A, Bencini P, Aroldi A, Cesana B, Braga M, Lonati F, Ponticelli C (1996) Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment. Clin Transplant 10, 461–9

    PubMed  CAS  Google Scholar 

  • Munoz P, Alvarez P, de Ory F, Pozo F, Rivera M, Bouza E (2002) Incidence and clinical characteristics of Kaposi sarcoma after solid organ transplantation in Spain: importance of seroconversion against HHV-8. Medicine (Baltimore) 81, 293–304

    Article  Google Scholar 

  • Nagy S, Gyulai R, Kemeny L, Szenohradszky P, Dobozy A (2000) Iatrogenic Kaposi’s sarcoma: HHV8 positivity persists but the tumors regress almost completely without immunosuppressive therapy. Transplantation 69, 2230–1

    Article  PubMed  CAS  Google Scholar 

  • Parravicini C, Olsen SJ, Capra M, Poli F, Sirchia G, Gao SJ, Berti E, Nocera A, Rossi E, Bestetti G, Pizzuto M, Galli M, Moroni M, Moore PS, Corbellino M (1997) Risk of Kaposi’s sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi’s sarcoma patients. Blood 90, 2826–9

    PubMed  CAS  Google Scholar 

  • Pellet C, Chevret S, Frances C, Euvrard S, Hurault M, Legendre C, Dalac S, Farge D, Antoine C, Hiesse C, Peraldi MN, Lang P, Samuel D, Calmus Y, Agbalika F, Morel P, Calvo F, Lebbe C (2002) Prognostic value of quantitative Kaposi sarcoma-associated herpesvirus load in posttransplantation Kaposi sarcoma. J Infect Dis 186, 110–3

    Article  PubMed  Google Scholar 

  • Penn I (1994) De novo tumors in pediatric organ transplant recipients. Transplant Proc 26, 1–2

    PubMed  CAS  Google Scholar 

  • Penn I (1997) Kaposi’s sarcoma in transplant recipients. Transplantation 64, 669–73

    Article  PubMed  CAS  Google Scholar 

  • Plancoulaine S, Abel L, van Beveren M, Tregouet DA, Joubert M, Tortevoye P, de The G, Gessain A (2000) Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 356, 1062–5

    Article  PubMed  CAS  Google Scholar 

  • Qunibi W, Akhtar M, Sheth K, Ginn HE, Al-Furayh O, DeVol EB, Taher S (1988) Kaposi’s sarcoma: the most common tumor after renal transplantation in Saudi Arabia. Am J Med 84, 225–32

    Article  PubMed  CAS  Google Scholar 

  • Qunibi W, Al-Furayh O, Almeshari K, Lin SF, Sun R, Heston L, Ross D, Rigsby M, Miller G (1998) Serologic association of human herpesvirus eight with posttrans-plant Kaposi’s sarcoma in Saudi Arabia. Transplantation 65, 583–5

    Article  PubMed  CAS  Google Scholar 

  • Rabkin CS, Shepherd FA, Wade JA (1999) Human herpesvirus 8 and renal transplantation. N Engl J Med 340, 1045–6

    Article  PubMed  CAS  Google Scholar 

  • Regamey N, Tamm M, Wernli M, Witschi A, Thiel G, Cathomas G, Erb P (1998) Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 339, 1358–63

    Article  PubMed  CAS  Google Scholar 

  • Rezeig MA, Fashir BM, Hainau B, Al Ashgar HI (1997) Kaposi’s sarcoma in liver transplant recipients on FK506: two case reports. Transplantation 63, 1520–1

    PubMed  CAS  Google Scholar 

  • Roque-Afonso AM, Feray C, Samuel D, Simoneau D, Roche B, Emile JF, Gigou M, Shouval D, Dussaix E (2002) Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors. Gut 50, 95–9

    Article  PubMed  CAS  Google Scholar 

  • Sachsenberg-Studer EM, Dobrynski N, Sheldon J, Schulz TF, Pechere M, Nador RG, Spiliopoulos A, Nicod L, Saurat JH (1999) Human herpes-virus 8 seropositive patient with skin and graft Kaposi’s sarcoma after lung transplantation. J Am Acad Dermatol 40, 308–11

    Article  PubMed  CAS  Google Scholar 

  • Schatz O, Monini P, Bugarini R, Neipel F, Schulz TF, Andreoni M, Erb P, Eggers M, Haas J, Butto S, Lukwiya M, Bogner JR, Yaguboglu S, Sheldon J, Sarmati L, Goebel FD, Hintermaier R, Enders G, Regamey N, Wernli M, Sturzl M, Rezza G, Ensoli B (2001) Kaposi’s sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J Med Virol 65, 123–32

    Article  PubMed  CAS  Google Scholar 

  • Shepherd FA, Maher E, Cardella C, Cole E, Greig P, Wade JA, Levy G (1997) Treatment of Kaposi’s sarcoma after solid organ transplantation. J Clin Oncol 15, 2371–7

    PubMed  CAS  Google Scholar 

  • Shmueli D, Shapira Z, Yussim A, Nakache R, Ram Z, Shaharabani E (1989) The incidence of Kaposi sarcoma in renal transplant patients and its relation to immuno-suppression. Transplant Proc 21, 3209–10

    PubMed  CAS  Google Scholar 

  • Sleiman C, Mal H, Roue C, Groussard O, Baldeyrou P, Olivier P, Fournier M, Pariente R (1997) Bronchial Kaposi’s sarcoma after single lung transplantation. Eur Respir J 10, 1181–3

    Article  PubMed  CAS  Google Scholar 

  • Spira TJ, Lam L, Dollard SC, Meng YX, Pau CP, Black JB, Burns D, Cooper B, Hamid M, Huong J, Kite-Powell K, Pellett PE (2000) Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol 38, 2174–80

    PubMed  CAS  Google Scholar 

  • Sungur C, Bozdogan O, Sungur A, Oymak O, Yasavul U, Turgan C, Caglar S (1995) Lymphadenopathic aggressive Kaposi’s sarcoma in a renal transplant recipient with HLA-DR2 and HLA-DR5 antigens. Nephron 69, 122–3

    Article  PubMed  CAS  Google Scholar 

  • Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G (1998) Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 90, 395–7

    Article  PubMed  CAS  Google Scholar 

  • Woodle ES, Hanaway M, Buell J, Gross T, First MR, Trofe J, Beebe T (2001) Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry. Transplant Proc 33, 3660–1

    Article  PubMed  CAS  Google Scholar 

  • Zahger D, Lotan C, Admon D, Klapholz L, Kaufman B, Shimon D, Woolfson N, Gotsman MS (1993) Very early appearance of Kaposi’s sarcoma after cardiac transplantation in Sephardic Jews. Am Heart J 126, 999–1000

    Article  PubMed  CAS  Google Scholar 

  • Zhu L, Wang R, Sweat A, Goldstein E, Horvat R, Chandran B (1999) Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells. Virology 256, 381–92

    Article  PubMed  CAS  Google Scholar 

  • Zong JC, Ciufo DM, Alcendor DJ, Wan X, Nicholas J, Browning PJ, Rady PL, Tyring SK, Orenstein JM, Rabkin CS, Su IJ, Powell KF, Croxson M, Foreman KE, Nickoloff BJ, Alkan S, Hayward GS (1999) High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi’s sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol 73, 4156–70

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Marcelin, A.G., Calvez, V., Dussaix, E. (2007). KSHV After an Organ Transplant: Should We Screen?. In: Boshoff, C., Weiss, R.A. (eds) Kaposi Sarcoma Herpesvirus: New Perspectives. Current Topics in Microbiology and Immunology, vol 312. Springer, Berlin, Heidelberg . https://doi.org/10.1007/978-3-540-34344-8_9

Download citation

Publish with us

Policies and ethics